News and Trends 1 Nov 2022 J.P. Morgan launches life sciences private capital team …diseases, autoimmunity, AI/ML platforms, metabolic diseases and neuropsychology. The new team sits within J.P. Morgan Private Capital, a growth equity and private credit investment platform. The platform finances private companies… November 1, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
More News! 10 Dec 2024 Biotech in 2024: A retrospective …a potential paradigm shift in treatment, especially given its convenient oral administration. Jeremy Levin, CEO of Ovid Therapeutics, compares the rising success of GLP-1 therapies in cardiometabolic diseases to the… December 10, 2024 - 14 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 22 Nov 2022 Arecor to start second type 2 diabetes clinical trial …trial will be conducted at the Medical University of Graz, Austria, a research facility in metabolic diseases research and euglycemic clamp methodology, with Thomas Pieber as the trial’s principal investigator…. November 22, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Interview 26 Feb 2018 This Biotech Could Replace Opioids with Safe and Effective Pain Relief for Osteoarthritis …of drug discovery [and] different departments ranging from urology to metabolic diseases, and then later on working in the pain area,” Westbrook told me. During his time there, he came… February 26, 2018 - 9 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 25 Nov 2024 Evotec on the brink of acquisition: At what cost for the biotech industry? …pipeline spans over 200 co-owned assets, covering various therapeutic areas such as oncology, neurology, and metabolic diseases. Evotec also invests in early-stage biotech startups and academic spinouts, bridging the gap… November 25, 2024 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Startup Scout 30 Jun 2017 This Danish Biotech Thinks it Can Tackle the Obesity Epidemic Apart from boasting big players in the space of metabolic diseases including Novo Nordisk and Zealand Pharma, Copenhagen is a hotspot for research on obesity and diabetes. This week we… June 30, 2017 - 2 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email
News and Trends 14 Jun 2017 French Hepatitis Cure is on Track with Positive Phase I Results …gained attention in hepatobiliary and metabolic diseases, such as NASH, due to its favorable effect on liver regeneration and its ability to prevent liver fibrosis. On top of the positive… June 14, 2017 - 3 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email
News and Trends 30 Nov 2022 TrialSpark acquires immunodermatology portfolio and creates Libertas Bio …novel therapies. TrialSpark is focused on clinical stage assets in rheumatology, dermatology, CNS, and cardiometabolic diseases, with a focus on chronic diseases that are treated outside of a hospital setting…. November 30, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 4 Aug 2017 Demo Day: Meet the Latest Generation of Synbio Startups from RebelBio …and fuel their human trials at the same time. https://youtu.be/pBUJU3R8-T4?list=PLAMGx-_sKtpN2sRhWuyZ5zi5hQ0YnVMit Bonn Macy, from Phyteau Functionals, explains how his startup aims to tackle another of great health concerns: metabolic diseases, including… August 4, 2017 - 6 minutesmins - By Denise Neves Gameiro Share WhatsApp Twitter Linkedin Email
In Depth 3 Feb 2025 The biggest biotech funding rounds in January 2025 …metabolic disorders, autoimmune diseases, and hematology, which borught in $600 million, $450 million, and $225.5 million respectively, compared to just $140.65 million for oncology. Month-to-month comparison of biotech fundraising Below… February 3, 2025 - 4 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 4 Oct 2023 CAR-NK: Can natural killer cell therapy pick up from where CAR-T left off? …cancer and glioblastoma (brain tumor). A recent study conducted at MD Anderson found that the loss of metabolic fitness in CAR-NK is a mechanism of resistance, eventually resulting in tumor… October 4, 2023 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 7 Mar 2025 Catalonia: A biotech hub going from strength to strength, with Barcelona at its core …these trials, oncology is the leading area of research and accounted for 32% of the trials in 2024. There was also significant growth last year in clinical trials on metabolic… March 7, 2025 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email